biopharmaceutical - International Pharmaceutical Industry

Volume 15 Issue 4

What is the Right Validation Model? Practical Considerations and Applications

It is now widely accepted that validation in the life sciences industry follows a lifecycle model.1,2 What is not always clear is the specific model – or models – to...

19 December 2023 Volume 15 Issue 4 analysis | applications

Continue Reading →

Volume 15 Issue 4

Auto-injectors: A Revolutionary Leap in Drug Delivery

In recent years, the biopharmaceutical industry has experienced a paradigm shift with the increasing prominence of auto-injectors. In 2023 the global auto[1]injector...

19 December 2023 Volume 15 Issue 4 Auto-injectors | biopharmaceutical

Continue Reading →

News

Roche recalls new eye therapy Susvimo on leakage fears, aims for market return ‘within a year or so’

Just as doctors were starting to cozy up to Roche and Genentech’s new eye drug delivery therapy, the companies are pulling the product from U.S. shelves. Roche ha...

19 October 2022 News Biopharma | biopharmaceutical

Continue Reading →

News

Love Pharma moves to buy transdermal opioid-use disorder player

Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property co...

19 October 2022 News Biopharma | biopharmaceutical

Continue Reading →

News

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has...

19 October 2022 News biopharmaceutical | biopharmaceutical industries

Continue Reading →

News

Chemotherapy drug derived from fungus shows promise

Oxford University researchers have collaborated with biopharmaceutical company NuCana to assess a novel chemotherapy drug derived from a fungus. The results of a ...

13 October 2021 News biopharmaceutical | Chemotherapy

Continue Reading →

News

AiPharma forms alliance with Appili Therapeutics

Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Th...

6 October 2021 News AiPharma | Appili Therapeutics

Continue Reading →

Volume 13 Issue 3

At the Forefront of Innovative Therapeutic Excellence Since 2006

Pharmaceutical and Biopharmaceutical sciences continue to find new applications, new modalities and a new class of compounds that can improve life expectancy and sta...

13 September 2021 Volume 13 Issue 3 biopharmaceutical | BSP Pharmaceuticals

Continue Reading →

News

The BIA welcomes the release of the AMR Industry Alliance’s first progress report

The BIA today welcomes the release of the AMR Industry Alliance’s first progress report assessing the action being taken to tackle antimicrobial resis...

19 January 2018 News AMR | antimicrobial resistance

Continue Reading →

News

Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices

Phillips-Medisize, a Molex company, announces its initial investment to expand the capabilities of the 380,000 square foot Molex Little Rock facility to include a FD...

7 December 2017 News biopharmaceutical | connected health

Continue Reading →